Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?

To: Roger Bodine who wrote (636)	7/18/1998 12:23:00 PM
From: Due Diligence	Read Replies (1) \| Respond to of 4028

Marc: Absolutely agree about putting in a limit order above the ask to protect yourself. I NEVER put in market orders to buy or sell. Prefer limit for protection. JMOO. Also,this excerpt from the July 9, 1997 news release shows the potential of "antisense therapies".Especially the last sentence. Hmmmmmmmm. CYGS? Jimbo >>>According to a March 96 analysis by Scrip Reports, "By the year 2000 the total value of the market for antisense therapies is expected to be $1.1 billion. And this figure is expected to nearly double to $2.12 billion by the year 2005. " It was estimated that the figure will be many times higher when a dependable delivery mechanism is available. "Although the term 'antisense' is not a household word, it is well recognized in the realm of biotech companies exploring leading edge genetic therapies." said Mr. Mealey, "In my view, Antisense therapeutics is the singular most significant medical break through since the discovery of effective vaccines." <<<